FDA found no violations at trial sites regarding Pfizer’s Lyme disease vaccine
A U.S. health regulator found no violations at clinical centres run by Care Access for Pfizer and French partner Valneva in a trial of a candidate vaccine against Lyme disease, a contract research firm.
POPULAR POSTS
LIVE STREAM
